Merck & Co., Inc. (BIT:1MRKX)

Market Cap	175.63B
Revenue (ttm)	59.14B
Net Income (ttm)	16.13B
Shares Out	n/a
EPS (ttm)	6.36
PE Ratio	10.89
Forward PE	9.00
Dividend	2.93 (4.24%)
Ex-Dividend Date	Mar 14, 2025

Volume	377
Average Volume	247
Open	71.10
Previous Close	69.30
Day's Range	69.10 - 71.30
52-Week Range	65.40 - 126.40
Beta	n/a
RSI	53.74
Earnings Date	Jul 29, 2025

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janu...

• Industry: Pharmaceutical Preparations
• Founded: 1891
• Employees: 75,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1MRKX

Financial Performance

In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.

Financial numbers in USD